ROC curve analysis revealed that the CCL17 levels exhibited the best performance (AUC 0.89; 95% CI 0.74–1.00) and were superior to the ILD-GAP index (AUC 0.81; 95% CI 0.66–0.95) (Fig. 2D). This evidence concerns the gene CCL17 and interstitial lung disease.